Valid

GB/T 42077-2022Biotechnology - Requirements for evaluating the performance of quantification methods for nucleic acid target sequences - qPCR and dPCR (English PDF)

生物技术 核酸靶序列定量方法的性能评价要求 qPCR法和dPCR法

Preview PDF

This is a limited preview

Buy now to download the full PDF (45 pages)

Need quotation for your management?

Get a formal quotation for GB/T 42077-2022 in 30 minutes.

Issued by

State Administration for Market Regulation, China National Standardization Administration

Level / Type

National · Recommended

Issue date

December 30, 2022

Implementation date

December 30, 2022

Scope

GB/T 42077-2022 is the English-translated version of 生物技术 核酸靶序列定量方法的性能评价要求 qPCR法和dPCR法.

GB/T 42077-2022 is the Chinese standard "Biotechnology - Requirements for evaluating the performance of quantification methods for nucleic acid target sequences - qPCR and dPCR".

Its scope clause reads: This document specifies general requirements for the performance evaluation and quality assurance of methods for the quantification of nucleic acid target sequences.

This document is applicable to the quantitative determination of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) target sequences by digital PCR (dPCR) or real-time quantitative PCR (qPCR) amplification techniques.

Applicable target sequence nucleic acid molecules include double-stranded DNA (dsDNA), such as genomic DNA (gDNA) and plasmid DNA; single-stranded DNA (ssDNA), complementary DNA (cDNA), single-stranded RNA (ssRNA) including ribosomal RNA (rRNA) and messenger RNA (mRNA); and double-stranded RNA, including long and short non-coding RNA [microRNA (miRNA) and small interfering RNA (siRNA), etc.].

This document is applicable to nucleic acids extracted from nucleic acids of biological origin (such as viruses, prokaryotic cells and eukaryotic cells), from cell-free biological fluid samples (such as plasma or cell matrix), and from nucleic acids of non-biological origin in vitro [such as oligonucleotides, synthetic gene fragments and in vitro transcribed (IVT) RNA].

This document is not applicable to the quantification of DNA oligonucleotides that are too short (< 50 bases).

This document covers: - assay design, including quantification strategies (qPCR standard curve method, dPCR molecular counting method, qPCR relative quantification method, dPCR ratio quantification method) and the use of controls; - quantification of total nucleic acid mass concentration and quality control of nucleic acid samples, including the assessment of nucleic acid quality (purity and integrity); - PCR assay design, optimization, bioinformatics and in vitro specificity testing; - data quality control and analysis, including acceptance criteria, threshold setting and normalization methods; - method validation according to the specific requirements of qPCR/dPCR (precision, linearity, limit of quantification, limit of detection, trueness and robustness); - methods for establishing metrological traceability and evaluating measurement uncertainty.

This document does not specify requirements or acceptance criteria for the sampling of biological material or for the processing of biological samples (such as collection, preservation, transport, storage, handling and nucleic acid extraction).

Nor does it specify requirements and acceptance criteria for special applications (such as food or clinical application fields, where special matrix problems may arise).

Found what you need?

Document preview — GB/T 42077-2022

National Standard of the People's Republic of China

ICS
07.080
Classification
A 40

Issued by: State Administration for Market Regulation, China National Standardization Administration

Contents

  • Foreword
  • 1 Scope
  • 2 Normative references
  • 3 Terms and definitions
  • 4 Design of the measurement procedure
  • 5 Sample quality control - Total amount, integrity and purity of nucleic acids
  • 6 Design and optimization of methods for the quantification of nucleic acid target sequences
  • 7 Data quality control and analysis
  • 8 Validation of quantitative measurement methods for nucleic acids
  • 9 Traceability and comparability of quantitative measurement methods for nucleic acids
  • 10 Measurement uncertainty of qPCR and dPCR measurements
  • 11 Report
  • Annex A (informative) Spectrophotometry
  • Annex B (informative) Nucleic acid integrity
  • Annex C (informative) PCR amplification efficiency
  • Annex D (informative) Measurement uncertainty
  • Annex E (informative) MIQE and dMIQE checklists
  • Bibliography

Foreword

This document is drafted in accordance with the rules given in GB/T 1.1-2020 Directives for standardization - Part 1: Rules for the structure and drafting of standardizing documents.

This document is identical to ISO 20395:2019 Biotechnology - Requirements for evaluating the performance of quantification methods for nucleic acid target sequences - qPCR and dPCR.

Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. The issuing body of this document shall not be held responsible for identifying any or all such patent rights.

This document was proposed by and is under the jurisdiction of the National Technical Committee on Biochemical Testing of Standardization Administration of China (SAC/TC 387).

Drafting organizations of this document: National Institute of Measurement and Testing Technology, National Institute of Metrology, China, West China Hospital of Sichuan University, Shenzhen Association of Analysis and Testing, Academy of Military Medical Sciences, Institute of Quality Standards and Testing Technology for Agro-Products of the Chinese Academy of Agricultural Sciences, Qingdao Ruiside Biotechnology Co., Ltd., General Biol (Anhui) Co., Ltd., Chengdu Shilian Kangjian Biotechnology Co., Ltd.

1 Scope

This document specifies general requirements for the performance evaluation and quality assurance of methods for the quantification of nucleic acid target sequences.

This document is applicable to the quantitative determination of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) target sequences by digital PCR (dPCR) or real-time quantitative PCR (qPCR) amplification techniques. Applicable target sequence nucleic acid molecules include double-stranded DNA (dsDNA), such as genomic DNA (gDNA) and plasmid DNA; single-stranded DNA (ssDNA), complementary DNA (cDNA), single-stranded RNA (ssRNA) including ribosomal RNA (rRNA) and messenger RNA (mRNA); and double-stranded RNA, including long and short non-coding RNA [microRNA (miRNA) and small interfering RNA (siRNA), etc.].

This document is applicable to nucleic acids extracted from nucleic acids of biological origin (such as viruses, prokaryotic cells and eukaryotic cells), from cell-free biological fluid samples (such as plasma or cell matrix), and from nucleic acids of non-biological origin in vitro [such as oligonucleotides, synthetic gene fragments and in vitro transcribed (IVT) RNA].

This document is not applicable to the quantification of DNA oligonucleotides that are too short (< 50 bases).

This document covers:

- assay design, including quantification strategies (qPCR standard curve method, dPCR molecular counting method, qPCR relative quantification method, dPCR ratio quantification method) and the use of controls;

- quantification of total nucleic acid mass concentration and quality control of nucleic acid samples, including the assessment of nucleic acid quality (purity and integrity);

- PCR assay design, optimization, bioinformatics and in vitro specificity testing;

- data quality control and analysis, including acceptance criteria, threshold setting and normalization methods;

- method validation according to the specific requirements of qPCR/dPCR (precision, linearity, limit of quantification, limit of detection, trueness and robustness);

- methods for establishing metrological traceability and evaluating measurement uncertainty.

This document does not specify requirements or acceptance criteria for the sampling of biological material or for the processing of biological samples (such as collection, preservation, transport, storage, handling and nucleic acid extraction). Nor does it specify requirements and acceptance criteria for special applications (such as food or clinical application fields, where special matrix problems may arise).

2 Normative references

The contents of the following documents constitute, through normative references in the text, indispensable provisions of this document. For dated references, only the edition corresponding to that date applies to this document. For undated references, the latest edition (including all amendments) applies to this document.

ISO/IEC Guide 98-3:2008 Uncertainty of measurement - Part 3: Guide to the expression of uncertainty in measurement (GUM:1995)

Note: GB/T 27418-2017 Evaluation and expression of uncertainty in measurement (ISO/IEC Guide 98-3:2008, MOD).

ISO/IEC Guide 99 International vocabulary of metrology - Basic and general concepts and associated terms (VIM)

3 Terms and definitions

For the purposes of this document, the terms and definitions given in ISO/IEC Guide 99 and the following apply.

3.1 amplicon

Specific DNA fragment produced by a DNA amplification technique (such as the polymerase chain reaction, PCR).

[Source: ISO 13495:2013, 3.3.1]

3.2 amplification plot

Plot representing the reporter signal (usually a fluorescence signal) generated during a qPCR or dPCR reaction.

Note 1: For qPCR and some dPCR systems, the amplification plot shows the relationship between the cycle number (X axis) and the fluorescence signal (Y axis).

Note 2: For end-point dPCR, the fluorescence signal of each dPCR partition is collected. For a single fluorophore, a one-dimensional amplification plot shows the total number of partitions (X axis) and the end-point fluorescence signal (Y axis); a multi-dimensional amplification plot shows the fluorescence signal of each detection channel on each axis.

3.3 calibrate curve; standard curve

Expression of the relation between indication and corresponding measured quantity value.

[Source: ISO/IEC Guide 99:2007, 4.31, modified]

3.4 calibrator

Measurement standard used in calibration.

Note: The term "calibrator" is only used in certain fields.

Example: In studies involving several qPCR multi-well plates or several qPCR experiments, a qPCR inter-plate calibrator is usually included in each plate to compensate for differences in data between plates caused by instrument measurement factors such as baseline and threshold setting. The inter-plate calibrator contains a target sequence detectable by the PCR assay and is measured with the same PCR assay as the samples under study.

[Source: ISO/IEC Guide 99:2007, 5.12, modified]

3.5 complementary DNA; cDNA

Single-stranded DNA, complementary to the template RNA, synthesized by the action of reverse transcriptase, which serves as a template for DNA amplification.

3.6 copy number

Number of molecules (copies) containing a specific nucleotide sequence.

[Source: ISO 16577:2016, 3.28, modified]

3.7 copy number concentration

Number of molecules (copies) containing a specific nucleotide sequence per unit volume.

3.8 quantification cycle; Cq

<qPCR> cycle number at which the fluorescence generated by the reaction exceeds a threshold sufficient to distinguish it from the background signal.

Note 1: Quantification cycle is a general term covering threshold cycle (Ct), crossing point (Cp), take-off point and all other instrument-specific terms for the cycle used to quantify the concentration of the target sequence in qPCR analysis.

Note 2: The quantification cycle is based on a threshold applied to all samples, or on regression analysis of the signal of each sample.

[Source: ISO 16577:2016, 3.32, modified]

3.9 delta Cq

Difference between two Cq values, delta Cq = Cq(1) - Cq(2).

3.10 digital PCR; dPCR

Process in which the nucleic acid template is distributed over a number of reaction partitions of equal volume, each partition containing or not containing one or more copies of the target sequence (nucleic acid template), the target sequence is amplified by PCR and the specific PCR product is detected, and the concentration or copy number of the target sequence is then calculated from the proportion of positive droplets and the principle of the Poisson distribution.

Note 1: It is assumed that, during partitioning, the nucleic acid target sequences are distributed randomly and independently among the partitions.

Note 2: Positive and negative partitions are usually counted by end-point detection of the PCR products after thermal cycling; some dPCR platforms can also monitor the PCR products in real time by qPCR.

3.11 gene of interest; GOI

Gene target sequence under study.

3.12 lambda value; lambda

Average number of targets per partition, calculated from the proportion of droplets in which amplification has occurred.

Note: The number of positive partitions (NP) and the total number of partitions (NT) are the parameters necessary for calculating lambda in dPCR.

3.13 limit of quantification; LOQ

Lowest concentration or content of a nucleic acid target sequence detected in a given volume of test sample under specified experimental conditions, the detection result having a defined trueness and precision and being usable for reasonable statistical analysis.

Note: It is usually expressed as a signal or measured (true) value that will produce an estimate with a specified coefficient of variation (CV).

[Source: ISO 16577:2016, 3.91, modified]

3.14 limit of detection; LOD

Measured quantity value obtained by a given measurement procedure, for which the probability of falsely claiming the absence of a component in a sample is beta and the probability of falsely claiming its presence is alpha.

[Source: ISO/IEC Guide 99:2007, 4.18, modified]

3.15 linearity

Relationship, described by the analysis with a method, by which the instrument response signal or result provided within a given range is proportional to the concentration of the nucleic acid target sequence determined in the laboratory sample.

Note 1: In qPCR, the threshold cycle is inversely proportional to the logarithm of the concentration of the nucleic acid target sequence.

Note 2: The term linearity is usually associated with the linear range of a method, and refers to the ability of a method to give responses or results directly proportional to the concentration of the nucleic acid target sequence.

[Source: ISO 16577:2016, 3.92, modified]

3.16 measurand

Quantity intended to be measured.

Note 1: The specification of a measurand requires knowledge of the kind of quantity and a description of the state of the phenomenon, body or substance carrying the quantity, including any relevant component and the chemical entities involved.

Note 2: In the second edition of the VIM and in IEC 60050-300:2001, the measurand is defined as the quantity subject to measurement.

Note 3: The measurement, including the measuring system and the conditions under which the measurement is carried out, might change the phenomenon, body or substance under study, so that the quantity being measured may differ from the measurand as defined. In this case, appropriate correction is necessary.

Example 1: The number of target gene copies detected by PCR is affected by the amplicon size of the PCR assay and by the fragment size of the template (approx. < amplicon size).

Example 2: When double-stranded DNA in the sample is denatured to single-stranded DNA, the dPCR quantification is affected.

[Source: ISO/IEC Guide 99:2007, 2.23, modified]

3.17 melting curve

Curve describing, by analysis, the degree of dissociation of the DNA double-helix structure during heating.

[Source: ISO 16577:2016, 3.107, modified]

3.18 melting temperature; Tm

Since the DNA double helix dissociates over a range of temperatures rather than at one specific temperature, the temperature at which 50% of the double-stranded DNA helix has dissociated is taken as the melting temperature.

[Source: ISO 16577:2016, 3.108]

3.19 messenger RNA; mRNA

Subtype of ribonucleic acid that serves as a template directing protein synthesis.

3.20 no template control; NTC

Control reaction containing all reagents except the nucleic acid template.

Note: This control is used to demonstrate the absence of nucleic acid contamination. For example, in a no template control, a corresponding volume of nucleic-acid-free water is added to the reaction in place of the template DNA. The term "PCR reagent control" is sometimes also used.

3.21 normalization

Correction of the measurement result of a nucleic acid target sequence by subtracting (Cq scale) or dividing by (linear scale) one or more parameters reflecting non-specific technical factors.

3.22 partitions

Droplets or reaction wells of equal volume into which the mixture of dPCR reagents and template is randomly distributed, and which are then amplified by PCR.

3.23 PCR assay; assay

Measurement method by qPCR (3.25) or dPCR (3.10) that identifies and/or quantifies a nucleic acid target sequence using specified oligonucleotide primers (and, in some cases, one or more probes).

3.24 PCR efficiency; E

Ratio of the amount of molecules (product) obtained by amplification in each PCR cycle to the template.

Example: If a test tube contains 100 target molecules and, after one PCR cycle, contains 180 molecules, then E = 0.8. The calculated amplification efficiency is expressed as a percentage of 1 or as a fraction; an efficiency of 100% corresponds to doubling in one cycle.

3.25 quantitative real-time PCR; qPCR

Polymerase chain reaction process combining in vitro amplification of a specific DNA fragment with real-time detection and quantification of the specific PCR product during amplification by means of the accumulation of a fluorescence signal.

Note: When the PCR reaction starts and the specific DNA sequence is replicated, the fluorescence signal emitted by the fluorescent molecules formed is proportional to the amount of DNA present (in theory, the original amount of the specific DNA in the starting template can be inferred by back-calculation).

[Source: ISO 16577:2016, 3.162, modified]

3.26 reference gene; endogenous gene

Target gene present at an almost constant copy number concentration in every biological sample, insensitive to reaction fluctuations caused by changes in biological or experimental conditions, or stable within a particular species or population.

Note: Reference genes were formerly called housekeeping genes. However, when RNA is measured, many target sequences that are not housekeeping genes can also be used, so the preferred term is now reference gene.

3.27 reverse transcription; RT

Process by which, under appropriate conditions, reverse transcriptase synthesizes cDNA with RNA as template, using one or more oligonucleotide primers.

[Source: ISO 16577:2016, 3.180, modified]

3.28 reverse transcription efficiency; RT efficiency

Percentage of the RNA template taking part in the reverse transcription reaction that is actually converted into synthesized cDNA.

Example: An RT efficiency of 80% means that 80% of the RNA template is converted into cDNA.

3.29 RT minus control; RT(-)

RT-PCR containing the nucleic acid template of the test sample and all amplification reagents except reverse transcriptase.

Note: The RT minus control is used in the quantification of RNA to measure the background produced by residual gDNA in the sample.

3.30 reverse transcription dPCR; RT-dPCR

Process in which an RNA strand is first reverse transcribed by reverse transcriptase into the DNA complementary to it (complementary DNA or cDNA), and the synthesized cDNA is then used as template for amplification by dPCR.

Note 1: This process can be one-step or two-step.

Note 2: In one-step RT-dPCR, the RT and dPCR amplification steps are carried out sequentially in the same tube using gene-specific primers.

Note 3: In two-step RT-dPCR, the RT and dPCR stages are carried out as two separate reactions. In this case, the RT step can use non-specific primers (i.e. oligo dT primers and/or a mixture of random oligonucleotides) to generate total cDNA from all the transcripts in the RNA sample. This cDNA serves as template, to which gene-specific PCR primers are added to amplify the target sequence for subsequent dPCR analysis.

3.31 reverse transcription qPCR; RT-qPCR

Process in which an RNA strand is first reverse transcribed by reverse transcriptase into the DNA complementary to it (complementary DNA or cDNA), and the synthesized cDNA is then used as template for amplification by qPCR.

Note: This process can be one or two steps, as for RT-dPCR.

[Source: ISO 16577:2016, 3.181, modified]

3.32 sample

Representative small portion or small quantity taken from a bulk or from a batch of samples.

[Source: ISO 16577:2016, 3.185]

3.33 specificity; analytical specificity

Ability of a measurement procedure to determine only what is intended to be quantified in the sample.

Example: The specificity of a PCR assay refers to its ability to detect only the target sequence, the quantification of the target sequence not being affected by cross-reactivity with related or potentially interfering nucleic acids or with sample-related conditions.

[Source: ISO 15193:2009, 3.9, modified]

3.34 single nucleotide polymorphism; SNP

DNA sequence polymorphism within a population caused by a variation of a single nucleotide at the level of the gene sequence.

[Source: ISO 25720:2009, 4.23]

3.35 single nucleotide variant; SNV

DNA sequence variant caused by a difference of a single nucleotide A, T, C or G in the genome (or other target sequence) from the reference template.

3.36 target sequence; nucleic acid target sequence

DNA sequence intended to be detected (for example by PCR).

[Source: ISO 16577:2016, 3.203]

3.37 template

Sequence of complementary bases used for the synthesis of a target DNA or RNA strand.

[Source: ISO 16577:2016, 3.206]

3.38 test sample

Sample, obtained by processing all or part of a sample, used for testing or analysis.

[Source: ISO 16577:2016, 3.210]

3.39 total nucleic acid

Total amount of nucleic acid in the sample obtained after nucleic acid extraction from a specimen, generally expressed as a mass concentration.

Note: In a particular extract, total nucleic acid includes most species (such as DNA or RNA).

4 Design of the measurement procedure

4.1 General

The experimental design for nucleic acid quantification shall include the selection of an appropriate sample type and number of samples, the PCR reaction programme and number of cycles, the setting of controls, the randomness of nucleic acid fragments and the standardization of the experimental process. 4.2 to 4.4 outline the specific factors that should be considered. In method validation (8.2), the precision of detection of the nucleic acid target sequence over the range of samples to be measured is evaluated, and its accuracy should guide the setting of repeatability for routine analysis.

4.2 Quantification methods

4.2.1 Overview

The choice of quantification strategy depends on the actual application. Taking account of the application requirements, 4.2.2 to 4.2.5 describe the main methods that may be used and their application requirements.

Remaining clauses in the full document

  • 4.3 Normalization strategy
  • 4.4 Setting of controls
  • 5 Sample quality control - Total amount, integrity and purity of nucleic acids
  • 6 Design and optimization of methods for the quantification of nucleic acid target sequences
  • 7 Data quality control and analysis
  • 8 Validation of quantitative measurement methods for nucleic acids
  • 9 Traceability and comparability of quantitative measurement methods for nucleic acids
  • 10 Measurement uncertainty of qPCR and dPCR measurements
  • 11 Report
  • Annex A (informative) Spectrophotometry
  • Annex B (informative) Nucleic acid integrity
  • Annex C (informative) PCR amplification efficiency
  • Annex D (informative) Measurement uncertainty
  • Annex E (informative) MIQE and dMIQE checklists
  • Bibliography

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 45 pages — is available in the English PDF.

Referenced standards

How to Download GB/T 42077-2022

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Fast delivery

    After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
45 pages
Fast delivery
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

GB/T 42077-2022

$575.00